Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible.

A recently developed pinhole high-resolution SPECT system was used to measure striatal to non-specific binding ratios in rats (n = 9), after injection of the dopamine transporter ligand (123)I-FP-CIT, and to assess its test/retest reproducibility. For co-alignment purposes, the rat brain was imaged on a 1.5 Tesla clinical MRI scanner using a specially developed surface coil. The SPECT images showed clear striatal uptake. On the MR images, cerebral and extra-cerebral structures could be easily delineated. The mean striatal to non-specific [(123)I]FP-CIT binding ratios of the test/retest studies were 1.7 +/- 0.2 and 1.6 +/- 0.2, respectively. The test/retest variability was approximately 9%. We conclude that the assessment of striatal [(123)I]FP-CIT binding ratios in rats is highly reproducible.

[1]  Adriaan A. Lammertsma,et al.  The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease , 1996 .

[2]  J. Booij,et al.  Evaluation of high-resolution pinhole SPECT using a small rotating animal. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  J. Booij,et al.  [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease , 2001, Journal of Neural Transmission.

[4]  G. Uhl,et al.  Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. , 1993, Brain research. Molecular brain research.

[5]  H. Fukuyama,et al.  Issues in measuring glucose metabolism of rat brain using PET: the effect of Harderian glands on the frontal lobe , 1998, Neuroscience Letters.

[6]  E. Ronken,et al.  In vitro and in vivo characterization of newly developed iodinated 1‐{2‐[Bis(4‐fluorophenyl)methoxy]ethyl}piperazine derivatives in rats: Limited value as dopamine transporter SPECT ligands , 1996, Synapse.

[7]  W. Galpern,et al.  In vivo PET Imaging in rat of dopamine terminals reveals functional neural transplants , 1998, Annals of neurology.

[8]  Jan Booij,et al.  Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism , 1999, European Journal of Nuclear Medicine.

[9]  James F. Young,et al.  MicroPET: a high resolution PET scanner for imaging small animals , 1996, IEEE Nuclear Science Symposium Conference Record.

[10]  P M Bloomfield,et al.  PET scanners for small animals. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  H. Müller-Gärtner,et al.  Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  V. Dhawan,et al.  Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study , 2002, Synapse.

[13]  P. Voorn,et al.  Imaging of dopamine transporters in rats using high-resolution pinhole single-photon emission tomography , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  P. Acton,et al.  Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  N. Alpert,et al.  Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters , 1998, Synapse.

[16]  R. Jaszczak,et al.  Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT. , 1994, Physics in medicine and biology.

[17]  M. Phelps,et al.  PET: the merging of biology and imaging into molecular imaging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  J B Habraken,et al.  Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  M. Kaufman,et al.  Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum , 1991, Synapse.

[20]  P M Wanet,et al.  Physical and clinical evaluation of high-resolution thyroid pinhole tomography. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  Bruce H. Hasegawa,et al.  ECG-gated pinhole SPECT in mice with millimeter spatial resolution , 2000 .

[22]  H. Berendse,et al.  Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell , 2001, Annals of neurology.

[23]  Christian Kolbitsch,et al.  Evaluation of Striatal Dopamine Transporter Function in Rats by in Vivo β-[123I]CIT Pinhole SPECT , 2002, NeuroImage.

[24]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[25]  S. Wey,et al.  Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  J. Booij,et al.  [123I]FP‐CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP‐lesioned monkeys , 1997, Synapse.

[27]  L. Feldkamp,et al.  Practical cone-beam algorithm , 1984 .

[28]  S H Snyder,et al.  Positron emission tomographic imaging of the dopamine transporter with 11C‐WIN 35,428 reveals marked declines in mild Parkinson's disease , 1993, Annals of neurology.

[29]  K Minematsu,et al.  Positron Emission Tomography for Quantitative Determination of Glucose Metabolism in Normal and Ischemic Brains in Rats: An Insoluble Problem by the Harderian Glands , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[31]  R J Jaszczak,et al.  A filtered backprojection algorithm for pinhole SPECT with a displaced centre of rotation , 1994, Physics in medicine and biology.

[32]  Eileen O. Smith,et al.  Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease , 1995, Annals of neurology.

[33]  J. P. Huston,et al.  UNILATERAL 6-HYDROXYDOPAMINE LESIONS OF MESO-STRIATAL DOPAMINE NEURONS AND THEIR PHYSIOLOGICAL SEQUELAE , 1996, Progress in Neurobiology.

[34]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.

[35]  J D Speelman,et al.  [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[36]  Jan Booij,et al.  The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.

[37]  Willibald Gerschlager,et al.  Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β‐CIT SPECT study , 2002, Movement disorders : official journal of the Movement Disorder Society.

[38]  P. Acton,et al.  Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123I]IBF , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[39]  Michael E. Phelps,et al.  Quantitation in Positron Emission Computed Tomography , 1980 .

[40]  Hiroyuki Okada,et al.  Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: A double‐tracer positron emission tomography study , 1999, Annals of neurology.